Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSpine Centre of Southern Denmark

About this trial

Patients with newly diagnosed or known multiple myeloma with newly diagnosed vertebral lesion(s) will be invited to participate in a cross-sectoral randomized controlled trial. The trial will compare two groups of patients which either receive regular medical treatment of their vertebral lesion(s) or vertebroplasty in addition to regular medical treatment. Our goal is to investigate the effectiveness of vertebroplasty and determine the role of surgical treatment in the overall treatment of patients with multiple myeloma and vertebral lesion(s).

Eligibility criteria

Qualifiers

known multiple myeloma

verified lesion(s) between Th6-L5

4 or less fractures

relevant pain in 3 months or less

Disqualifiers

presence of neurologic deficit

psychological or psychiatric disorder hat is expected to interfere with compliance

Trial design

Treatments tested in this trial

  • Vertebroplasty

Treatment groups

90 Participants
are divided into 2 treatment groups